Provided by Tiger Fintech (Singapore) Pte. Ltd.

Oxford

51.91
+0.57001.11%
Post-market: 51.910.00000.00%16:43 EDT
Volume:403.60K
Turnover:20.62M
Market Cap:771.65M
PE:8.84
High:51.97
Open:50.96
Low:49.59
Close:51.34
Loading ...

Oxford Square Capital Reports Q1 2025 Earnings

TIPRANKS
·
2 hours ago

Oxford Industries, Inc.'s (NYSE:OXM) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simply Wall St.
·
24 Apr

MetaVia Announces Late-Breaking Poster Presentation on DA-1241 at the EASL Congress 2025

PR Newswire
·
23 Apr

Oxford Industries Is Maintained at Market Perform by Telsey Advisory Group

Dow Jones
·
23 Apr

Artemis Increases Stake in Oxford Instruments

TIPRANKS
·
22 Apr

BRIEF-Oxford Industries Expects Less Than 35% Of Goods From China In Fiscal 2025

Reuters
·
22 Apr

Oxford Industries Inc - Anticipates Selective Price Increases Starting Later in Fiscal 2025 - SEC Filing

THOMSON REUTERS
·
22 Apr

Oxford Industries: Cannot Predict Full Effect of Current or Future Tariff Policies and Its Diversification Efforts

THOMSON REUTERS
·
22 Apr

Oxford Industries Inc - to Increase Sourcing From Cambodia, India, Indonesia, Peru, Sri Lanka, Thailand, Turkey, Vietnam - SEC Filing

THOMSON REUTERS
·
22 Apr

Oxford Industries, Inc. (OXM): Among Most Expensive Stocks Insiders Are Buying After Trump’s Tariff Rollout

Insider Monkey
·
22 Apr

Oxford Instruments price target lowered to 2,750 GBp from 2,850 GBp at Deutsche Bank

TIPRANKS
·
18 Apr

Artemis Investment Management Increases Stake in Oxford Instruments

TIPRANKS
·
17 Apr

Oxford Industries Forms New Subsidiary

MT Newswires Live
·
17 Apr

Hold Rating Justified Amid Stable Performance and Tariff Concerns for Oxford Instruments

TIPRANKS
·
16 Apr

Oxford Economics Cuts U.K. 2026 Growth Forecast to 0.9% Due to Tariff Impact -- Market Talk

Dow Jones
·
15 Apr

Artemis Increases Stake in Oxford Instruments

TIPRANKS
·
15 Apr

MetaVia Announces Positive Top-Line Data From the 4-Week Phase 1 MAD Trial of DA-1726, a Novel 3:1 Ratio GLP-1 Glucagon Dual Receptor Agonist to Treat Obesity, Showing Compelling Weight Loss and Safety Effects With Potential Best-In-Class Glucose Control (GLP-1R), Waist Reduction (GCGR), and Tolerability

PR Newswire
·
15 Apr

Oxford Nanopore Technologies Announces LTIP and DBP Awards for Directors

TIPRANKS
·
15 Apr

Oxford Metrics Executes Share Buyback to Optimize Capital Structure

TIPRANKS
·
14 Apr

Chanel Boat Race: Who are favourites and where do Oxford and Cambridge race?

cityam
·
13 Apr